US7328056B2 - Magnetic resonance method and apparatus for classifying an atheroma - Google Patents

Magnetic resonance method and apparatus for classifying an atheroma Download PDF

Info

Publication number
US7328056B2
US7328056B2 US10/625,392 US62539203A US7328056B2 US 7328056 B2 US7328056 B2 US 7328056B2 US 62539203 A US62539203 A US 62539203A US 7328056 B2 US7328056 B2 US 7328056B2
Authority
US
United States
Prior art keywords
plaque
magnetic resonance
contrast agent
classifying
time duration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US10/625,392
Other versions
US20050033178A1 (en
Inventor
Stefan Assmann
Oliver Schreck
Paul Finn
Stephanie Shors
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens AG
Northwestern University
Original Assignee
Siemens AG
Northwestern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siemens AG, Northwestern University filed Critical Siemens AG
Priority to US10/625,392 priority Critical patent/US7328056B2/en
Assigned to SIEMENS AKTIENGESELLSCHAFT reassignment SIEMENS AKTIENGESELLSCHAFT ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FINN, PAUL, SHORS, STEPHANIE, ASSMANN, STEFAN, SCHRECK, OLIVER
Assigned to NORTHWESTERN UNIVERSITY, SIEMENS AKTIENGESELLSCHAFT reassignment NORTHWESTERN UNIVERSITY CORRECTIVE ASSIGNMENT TO RECORD ADDITIONAL RECEIVING PARTY, PREVIOUSLY RECORDED REEL 014325, FRAME 0418. Assignors: SHORES, STEPHANIE, FINN, PAUL, SCHRECK, OLIVER, ASSMANN, STEFAN
Publication of US20050033178A1 publication Critical patent/US20050033178A1/en
Application granted granted Critical
Publication of US7328056B2 publication Critical patent/US7328056B2/en
Expired - Fee Related legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves 
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves  involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Definitions

  • the present invention is directed to a method and apparatus for classifying an atheroma, and in particular to such a method and apparatus on the basis of magnetic resonance imaging.
  • Arteriosclerosis is a general term meaning a decrease in the natural elasticity of the wall of an artery. Such a decrease in elasticity can occur as a result of various pathological sources, one of which is the build-up of an atheroma, commonly referred to as a deposit or plaque, on or within the interior surface of the artery wall. Arteriosclerosis due to the presence of an atheroma is referred to atherosclerosis.
  • a stroke occurs when any of the significant vessels in the brain becomes sufficiently blocked so that oxygen deprivation in a region of the brain occurs.
  • a frequent cause of stroke is that some or all of an atheroma becomes dislodged, and is carried by the natural blood flow to one of the vessels feeding the brain, where it creates a blockage resulting in the aforementioned oxygen deprivation.
  • a method and apparatus for classifying plaque in a blood vessel of a living subject using magnetic resonance imaging wherein a first magnetic resonance image is produced with a first intensity distribution of a cross-section of a vessel containing plaque, and wherein a contrast agent is injected into the vascular system and a second magnetic resonance image of the cross-section of the vessel is produced with a second intensity distribution after a first time duration following the contrast agent injection, and wherein a third magnetic resonance image of the cross-section of the vessel is produced with a third intensity distribution after a second time duration following the injection of the contrast agent, and wherein the plaque is classified dependent on the respective intensity distributions of the magnetic resonance images.
  • the inventive method and apparatus allow classification of the plaque as being of a type known to be stable or prone to dislodgement. If the plaque is classified as being of the latter type, the patient is then at a higher risk of experiencing a stroke, due to dislodgement of the plaque and appropriate preventative steps can be taken.
  • the preventative steps can range from dietary changes to pharmacological treatment to surgical intervention, dependent on the degree of risk which is diagnosed to exist.
  • the tissue under examination will exhibit an enrichment phase during which the amount of contrast agent absorbed into the tissue in question will increase. This enrichment phase is then followed by a flushing phase, wherein the contrast agent is naturally eliminated from the tissue in question.
  • the first time duration lies within the enrichment phase of the contrast agent in the plaque.
  • the second time duration lies within the flushing phase of the contrast agent in the plaque, following the enrichment phase.
  • the first and second time durations can be in the range of minutes.
  • the same region in each of those images can be specified or defined, and the aforementioned intensity distributions within that region can be compared.
  • the intensity distributions in each image can be determined along a line through the cross-section of the vessel.
  • the classification of the plaque can include a first classification group including fat deposits (lipids).
  • Another classification group can include small vessels (neo-vessels).
  • Such small vessels in the vessel wall will flush the contrast agent with a different time dynamic than lipids, wherein the contrast agent is located in the fatty cell interspaces and is flushed from those interspaces.
  • a third classification group can be inflammations, and a fourth classification group can include connective tissue and scar tissue (fibrous tissue).
  • a further classification group can include calcifications.
  • the aforementioned magnetic resonance images are produced with a known FLASH sequence.
  • the known contrast agent Gd-DTPA is employed as the contrast agent.
  • FIG. 1 is a schematic block diagram of a magnetic resonance imaging apparatus operable in accordance with the inventive method.
  • FIG. 2 is a magnetic resonance image of the type obtained in accordance with the inventive method showing contrast agent absorption in plaque in the carotid artery, in an overview image.
  • FIGS. 3 , 4 and 5 are magnified exposures of the carotid artery shown in FIG. 2 , showing contrast agent absorption in plague in the carotid artery in accordance with the inventive method.
  • FIG. 6 is a profile curve illustrating the intensity distribution in accordance with the inventive method.
  • FIG. 1 is a schematic illustration of a magnetic resonance tomography apparatus for implementing the inventive method.
  • the basic components of the magnetic resonance tomography apparatus correspond to those of a conventional tomography apparatus, with the differences discussed below.
  • a basic field magnet 1 generates a temporally constant, strong magnetic field for the polarization or alignment of the nuclear spins in the examination region of a subject such as, for example, a part of a human body to be examined.
  • the high homogeneity of the basic magnetic field required for the magnetic resonance measurement is defined in a spherical measurement volume M into which the parts of the human body to be examined are introduced.
  • shim plates of ferromagnetic material are attached at suitable locations. Time-variable influences are eliminated by shim coils 2 that are driven by a shim power supply 15 .
  • a cylindrical gradient coil system 3 that is composed of three sub-windings is introduced into the basic field magnet 1 .
  • Each sub-winding is supplied with current by an amplifier 14 for generating a linear gradient field in one direction of the Cartesian coordinate system.
  • the first sub-winding of the gradient field system generates a gradient G x in the x-direction
  • the second sub-winding generates a gradient G y in the y-direction
  • the third sub-winding generates a gradient G z in the x-direction.
  • Each amplifier 14 has a digital-to-analog converter that is driven by a sequence controller 18 for the temporally correct generation of gradient pulses.
  • a radio-frequency antenna 4 is situated within the gradient field system 3 .
  • This antenna 4 converts the radio-frequency pulse output by a radio-frequency power amplifier 30 into a magnetic alternating field for exciting the nuclei and alignment of the nuclear spins of the examination subject or of the region of the subject to be examined.
  • a pulse sequence is employed having one or more radio frequency pulses and one or more gradient pulses
  • the radio-frequency antenna 4 also converts the alternating field emanating from the precessing nuclear spins, i.e. the nuclear spin echo signals, into a voltage that is supplied via an amplifier 7 to a radio-frequency reception channel 8 of a radio-frequency system 22 .
  • the radio-frequency system 22 also has a transmission channel 9 in which the radio-frequency pulses for exciting the nuclear magnetic resonance are generated.
  • the respective radio-frequency pulses are digitally represented as a sequence of complex numbers in the sequence controller 18 on the basis of a pulse sequence prescribed by the system computer 20 .
  • this number sequence is supplied via an input 12 to a digital-to-analog converter in the radio-frequency system 22 and from the latter to a transmission channel 9 .
  • the pulse sequences are modulated onto a high-frequency carrier signal having a base frequency corresponding to the resonant frequency of the nuclear spins in the measurement volume.
  • the switching from transmission mode to reception mode ensues via a transmission-reception diplexer 6 .
  • the radio-frequency antenna 4 emits the radio-frequency pulses for exciting the nuclear spins into the measurement volume M and samples resulting echo signals.
  • the correspondingly acquired magnetic resonance signals are phase-sensitively demodulated in the reception channel 8 of the radio-frequency system 22 and converted via a respective analog-to-digital converters into a real part and an imaginary part of the measured signal.
  • An image computer 17 reconstructs an image from the measured data acquired in this way.
  • the management of the measured data, of the image data and of the control programs ensues via the system computer 20 .
  • the sequence controller 18 controls the generation of the desired pulse sequences and the corresponding sampling of k-space.
  • the sequence controller 18 controls the temporally correct switching of the gradients, the emission of the radio-frequency pulses with defined phase and amplitude as well as the reception of the magnetic resonance signals.
  • the time base (clock) for the radio-frequency system 22 and the sequence controller 18 is made available by a synthesizer 19 .
  • the selection of suitable control programs for generating a magnetic resonance image as well as the presentation of the generated magnetic resonance image ensue via a terminal 21 that has a keyboard as well as one or more picture screens.
  • a contrast agent injector 23 is connected to a patient on the patient support 5 , via a catheter, and is controlled by the system computer 20 as to the timing of the contrast agent injections. Manual control also is possible.
  • the system computer 20 together with the sequence controller 18 , operates the magnetic resonance scanner, and the system computer 20 operates the contrast agent injector 23 in synchronism with each other so as to obtain a series of magnetic resonance images of the cross-section of a designated vessel that is known to contain plaque or is suspected of containing plaque.
  • images of a cross-section of the carotid artery are obtained.
  • FIG. 2 is an overall image of a slice of the patient containing the carotid artery in cross-section.
  • FIG. 3 is a first magnetic resonance image that is obtained with a first intensity distribution of the cross-section of the carotid artery that contains plaque, before the contrast agent injector 23 is operated to inject contrast agent.
  • the system computer 20 After obtaining the data for the image shown in FIG. 2 , the system computer 20 operates the contrast agent injector 23 to inject contrast agent into the vascular system of the patient.
  • data for a second magnetic resonance image of the same vessel cross-section with a second intensity distribution are obtained.
  • FIG. 4 Such a second magnetic resonance image is shown in FIG. 4 , wherein it can be seen that the plaque has absorbed the contrast agent.
  • Curves of the signal intensity distribution are shown in FIG. 6 , for an image before the contrast agent is injected, and, as examples, curves respectively showing the signal intensity one minute after the injection of the contrast agent and three minutes after the injection of the contrast agent.
  • the plaque is classified.
  • the terminal 21 can execute a classifier program, for example, or the data can be transferred to some other computer and/or to some other location for undertaking the classifications.
  • the first time duration, after which the second magnetic resonance image shown in FIG. 3 is obtained, is within the enrichment phase of the contrast agent in the plaque
  • the second time duration, after which the third magnetic resonance image shown in FIG. 4 is obtained is within the flushing phase of the contrast agent in the plaque.
  • the intensity distribution can be measured along a defined line in the images.
  • the classification of the plaque can include a number of classes, such as a class for plaque composed of deposits (lipids), a class for plaque composed of small vessels (neo-vessels), a class for plaque formed by inflammations, a class for plaque formed by fibrous tissue (connective tissue or scar tissue), and a class for plaque composed of calcifications.
  • the system computer 20 and the sequence controller 18 operate the magnetic resonance scanner in a known FLASH sequence for obtaining the images shown in FIGS. 2 , 3 , 4 and 5 .
  • the contrast agent employed preferably is Gd-DTPA, which is a known contrast agent for magnetic resonance imaging.

Abstract

In a method and apparatus for classifying plaque in a blood vessel of a living subject using magnetic resonance imaging, a first magnetic resonance image is produced with a first intensity distribution of a cross-section of a vessel containing plaque, and a contrast agent is injected into the vascular system and a second magnetic resonance image of the cross-section of the vessel is produced with a second intensity distribution after a first time duration following the contrast agent injection, and a third magnetic resonance image of the cross-section of the vessel is produced with a third intensity distribution after a second time duration following the injection of the contrast agent, and the plaque is classified dependent on the respective intensity distributions of the magnetic resonance images.

Description

BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention is directed to a method and apparatus for classifying an atheroma, and in particular to such a method and apparatus on the basis of magnetic resonance imaging.
2. Description of the Prior Art
Arteriosclerosis is a general term meaning a decrease in the natural elasticity of the wall of an artery. Such a decrease in elasticity can occur as a result of various pathological sources, one of which is the build-up of an atheroma, commonly referred to as a deposit or plaque, on or within the interior surface of the artery wall. Arteriosclerosis due to the presence of an atheroma is referred to atherosclerosis.
In addition to producing a health risk due to reduced to cardiovascular efficiency, blockage or partial blockage of an artery, or any blood vessel, has the potential to cause the occurrence of a stroke. A stroke occurs when any of the significant vessels in the brain becomes sufficiently blocked so that oxygen deprivation in a region of the brain occurs. A frequent cause of stroke is that some or all of an atheroma becomes dislodged, and is carried by the natural blood flow to one of the vessels feeding the brain, where it creates a blockage resulting in the aforementioned oxygen deprivation.
It is known that different types of deposits or plaque in the blood vessels have different tendencies to become dislodged, and therefore certain types of deposits or plaque are more likely to create a risk of stroke than other types. It is known that plaque formed by calcifications and fibrous tissue, such as connective tissue and scar tissue, is less likely to become dislodged from the vessel wall than plaque formed by lipids. Currently, however, there is no imaging technique which allows these different types of plaques to be classified so that the risk or potential for dislodgement, and thus a stroke, can be assessed.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide a method and apparatus for classifying plaque, thereby also allowing a risk diagnosis to be made as to the propensity of a patient to experience a stroke.
The above object is achieved in accordance with the principles of the present invention in a method and apparatus for classifying plaque in a blood vessel of a living subject using magnetic resonance imaging, wherein a first magnetic resonance image is produced with a first intensity distribution of a cross-section of a vessel containing plaque, and wherein a contrast agent is injected into the vascular system and a second magnetic resonance image of the cross-section of the vessel is produced with a second intensity distribution after a first time duration following the contrast agent injection, and wherein a third magnetic resonance image of the cross-section of the vessel is produced with a third intensity distribution after a second time duration following the injection of the contrast agent, and wherein the plaque is classified dependent on the respective intensity distributions of the magnetic resonance images.
The inventive method and apparatus allow classification of the plaque as being of a type known to be stable or prone to dislodgement. If the plaque is classified as being of the latter type, the patient is then at a higher risk of experiencing a stroke, due to dislodgement of the plaque and appropriate preventative steps can be taken. The preventative steps can range from dietary changes to pharmacological treatment to surgical intervention, dependent on the degree of risk which is diagnosed to exist.
As in any imaging employing the injection of a contrast agent, the tissue under examination will exhibit an enrichment phase during which the amount of contrast agent absorbed into the tissue in question will increase. This enrichment phase is then followed by a flushing phase, wherein the contrast agent is naturally eliminated from the tissue in question.
In an embodiment of the invention, the first time duration lies within the enrichment phase of the contrast agent in the plaque. In a further version of this embodiment, the second time duration lies within the flushing phase of the contrast agent in the plaque, following the enrichment phase. The first and second time durations can be in the range of minutes.
For insuring that the respective intensity distributions in the first, second and third magnetic resonance images are comparable to or correlated with each other, the same region in each of those images can be specified or defined, and the aforementioned intensity distributions within that region can be compared. Specifically, the intensity distributions in each image can be determined along a line through the cross-section of the vessel.
The classification of the plaque can include a first classification group including fat deposits (lipids). Another classification group can include small vessels (neo-vessels).
Such small vessels (neo-vessels) in the vessel wall will flush the contrast agent with a different time dynamic than lipids, wherein the contrast agent is located in the fatty cell interspaces and is flushed from those interspaces.
A third classification group can be inflammations, and a fourth classification group can include connective tissue and scar tissue (fibrous tissue). A further classification group can include calcifications.
Preferably the aforementioned magnetic resonance images are produced with a known FLASH sequence. Preferably the known contrast agent Gd-DTPA is employed as the contrast agent.
DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic block diagram of a magnetic resonance imaging apparatus operable in accordance with the inventive method.
FIG. 2 is a magnetic resonance image of the type obtained in accordance with the inventive method showing contrast agent absorption in plaque in the carotid artery, in an overview image.
FIGS. 3, 4 and 5 are magnified exposures of the carotid artery shown in FIG. 2, showing contrast agent absorption in plague in the carotid artery in accordance with the inventive method.
FIG. 6 is a profile curve illustrating the intensity distribution in accordance with the inventive method.
 DESCRIPTION OF THE PREFERRED EMBODIMENTS
FIG. 1 is a schematic illustration of a magnetic resonance tomography apparatus for implementing the inventive method. The basic components of the magnetic resonance tomography apparatus correspond to those of a conventional tomography apparatus, with the differences discussed below. A basic field magnet 1 generates a temporally constant, strong magnetic field for the polarization or alignment of the nuclear spins in the examination region of a subject such as, for example, a part of a human body to be examined. The high homogeneity of the basic magnetic field required for the magnetic resonance measurement is defined in a spherical measurement volume M into which the parts of the human body to be examined are introduced. For satisfying the homogeneity requirements and, in particular, for eliminating time-invariable influences, shim plates of ferromagnetic material are attached at suitable locations. Time-variable influences are eliminated by shim coils 2 that are driven by a shim power supply 15.
A cylindrical gradient coil system 3 that is composed of three sub-windings is introduced into the basic field magnet 1. Each sub-winding is supplied with current by an amplifier 14 for generating a linear gradient field in one direction of the Cartesian coordinate system. The first sub-winding of the gradient field system generates a gradient Gx in the x-direction, the second sub-winding generates a gradient Gy in the y-direction and the third sub-winding generates a gradient Gz in the x-direction. Each amplifier 14 has a digital-to-analog converter that is driven by a sequence controller 18 for the temporally correct generation of gradient pulses.
A radio-frequency antenna 4 is situated within the gradient field system 3. This antenna 4 converts the radio-frequency pulse output by a radio-frequency power amplifier 30 into a magnetic alternating field for exciting the nuclei and alignment of the nuclear spins of the examination subject or of the region of the subject to be examined. Usually a pulse sequence is employed having one or more radio frequency pulses and one or more gradient pulses The radio-frequency antenna 4 also converts the alternating field emanating from the precessing nuclear spins, i.e. the nuclear spin echo signals, into a voltage that is supplied via an amplifier 7 to a radio-frequency reception channel 8 of a radio-frequency system 22. The radio-frequency system 22 also has a transmission channel 9 in which the radio-frequency pulses for exciting the nuclear magnetic resonance are generated. The respective radio-frequency pulses are digitally represented as a sequence of complex numbers in the sequence controller 18 on the basis of a pulse sequence prescribed by the system computer 20. As a real part and an imaginary part, this number sequence is supplied via an input 12 to a digital-to-analog converter in the radio-frequency system 22 and from the latter to a transmission channel 9. In the transmission channel 9, the pulse sequences are modulated onto a high-frequency carrier signal having a base frequency corresponding to the resonant frequency of the nuclear spins in the measurement volume.
The switching from transmission mode to reception mode ensues via a transmission-reception diplexer 6. The radio-frequency antenna 4 emits the radio-frequency pulses for exciting the nuclear spins into the measurement volume M and samples resulting echo signals. The correspondingly acquired magnetic resonance signals are phase-sensitively demodulated in the reception channel 8 of the radio-frequency system 22 and converted via a respective analog-to-digital converters into a real part and an imaginary part of the measured signal. An image computer 17 reconstructs an image from the measured data acquired in this way. The management of the measured data, of the image data and of the control programs ensues via the system computer 20. On the basis of control programs, the sequence controller 18 controls the generation of the desired pulse sequences and the corresponding sampling of k-space. In particular, the sequence controller 18 controls the temporally correct switching of the gradients, the emission of the radio-frequency pulses with defined phase and amplitude as well as the reception of the magnetic resonance signals. The time base (clock) for the radio-frequency system 22 and the sequence controller 18 is made available by a synthesizer 19. The selection of suitable control programs for generating a magnetic resonance image as well as the presentation of the generated magnetic resonance image ensue via a terminal 21 that has a keyboard as well as one or more picture screens.
A contrast agent injector 23 is connected to a patient on the patient support 5, via a catheter, and is controlled by the system computer 20 as to the timing of the contrast agent injections. Manual control also is possible.
The system computer 20, together with the sequence controller 18, operates the magnetic resonance scanner, and the system computer 20 operates the contrast agent injector 23 in synchronism with each other so as to obtain a series of magnetic resonance images of the cross-section of a designated vessel that is known to contain plaque or is suspected of containing plaque. In the exemplary embodiment, images of a cross-section of the carotid artery are obtained.
FIG. 2 is an overall image of a slice of the patient containing the carotid artery in cross-section.
FIG. 3 is a first magnetic resonance image that is obtained with a first intensity distribution of the cross-section of the carotid artery that contains plaque, before the contrast agent injector 23 is operated to inject contrast agent. After obtaining the data for the image shown in FIG. 2, the system computer 20 operates the contrast agent injector 23 to inject contrast agent into the vascular system of the patient. After a first time duration, following the contrast agent injection, data for a second magnetic resonance image of the same vessel cross-section with a second intensity distribution are obtained. Such a second magnetic resonance image is shown in FIG. 4, wherein it can be seen that the plaque has absorbed the contrast agent.
After a second time duration following the contrast agent injection, data for a third magnetic resonance image of the same vessel cross-section, with a third intensity distribution, are obtained. This third magnetic resonance image is shown in FIG. 5 wherein, in comparison to FIG. 4, it can be seen that contrast agent has begun to be flushed out of the plaque.
Curves of the signal intensity distribution are shown in FIG. 6, for an image before the contrast agent is injected, and, as examples, curves respectively showing the signal intensity one minute after the injection of the contrast agent and three minutes after the injection of the contrast agent.
Based on these signal intensity distributions, and preferably employing a suitably programmed automatic electronic classifier, the plaque is classified. The terminal 21 can execute a classifier program, for example, or the data can be transferred to some other computer and/or to some other location for undertaking the classifications.
Preferably the first time duration, after which the second magnetic resonance image shown in FIG. 3 is obtained, is within the enrichment phase of the contrast agent in the plaque, and preferably the second time duration, after which the third magnetic resonance image shown in FIG. 4 is obtained, is within the flushing phase of the contrast agent in the plaque. As indicated in FIGS. 3, 4 and 5, the intensity distribution can be measured along a defined line in the images.
The classification of the plaque can include a number of classes, such as a class for plaque composed of deposits (lipids), a class for plaque composed of small vessels (neo-vessels), a class for plaque formed by inflammations, a class for plaque formed by fibrous tissue (connective tissue or scar tissue), and a class for plaque composed of calcifications.
Preferably, the system computer 20 and the sequence controller 18 operate the magnetic resonance scanner in a known FLASH sequence for obtaining the images shown in FIGS. 2, 3, 4 and 5.
The contrast agent employed preferably is Gd-DTPA, which is a known contrast agent for magnetic resonance imaging.
Although modifications and changes may be suggested by those skilled in the art, it is the intention of the inventors to embody within the patent warranted hereon all changes and modifications as reasonably and properly come within the scope of their contribution to the art.

Claims (33)

1. A computerized method for classifying plaque in a blood vessel of a living subject comprising the steps of:
implementing a magnetic resonance imaging sequence to obtain data representing a first magnetic resonance image with a first intensity distribution of a cross-section of a vessel containing plaque in a living subject;
injecting contrast agent that interacts with said plaque into the vascular system of said subject, said contrast agent interacting non-uniformly with said plaque with respect to time and thus producing different intensity distributions in said plaque in a time period;
in said time period, re-implementing said magnetic resonance imaging sequence to obtain data representing a second magnetic resonance image of said cross-section of said vessel and said plaque therein with a second intensity distribution after a first time duration following injection of said contrast agent;
in said time period, again re-implementing said magnetic resonance imaging sequence to obtain data representing a third magnetic resonance image of said cross-section of said vessel and said plaque therein with a third intensity distribution after a second time duration following injection of said contrast agent, said second and third intensity distributions differing from each other due to said non-uniform interaction of said contrast agent with said plaque in said time period; and
in a computer, classifying said plaque dependent on said first, second and third intensity distributions to produce a classification result and presenting said classification result in a visually perceptible display at said computer.
2. A method as claimed in claim 1 comprising classifying said plaque in different classes of plaque dependent on propensity to dislodge from said vessel.
3. A method as claimed in claim 1 comprising selecting said first time duration to lie within an enrichment phase of said contrast agent in said plaque.
4. A method as claimed in claim 1 comprising selecting said time duration as approximately one minute.
5. A method as claimed in claim 3 comprising selecting said second time duration to lie within a flushing phase of said contrast agent in said plaque, following said enrichment phase.
6. A method as claimed in claim 5 comprising selecting said second time duration as approximately three minutes.
7. A method as claimed in claim 1 comprising selecting a same region of said subject in each of said first, second and third magnetic resonance images and determining the respective first, second and third intensity distributions in said region.
8. A method as claimed in claim 7 comprising defining a same line in each of said first, second and third magnetic resonance images, and determining the respective first, second and third intensity distributions along said line.
9. A method as claimed in claim 1 comprising classifying said plaque in a plurality of classes including a class representing plaque composed of fat deposits.
10. A method as claimed in claim 1 comprising classifying said plaque in a plurality of classes including a class representing plaque composed of small vessels.
11. A method as claimed in claim 1 comprising classifying said plaque in a plurality of classes including a class representing plaque composed of inflammations.
12. A method as claimed in claim 1 comprising classifying said plaque in a plurality of classes including a class representing plaque composed of fibrous tissue.
13. A method as claimed in claim 1 comprising classifying said plaque in a plurality of classes including a class representing plaque composed of calcifications.
14. A method as claimed in claim 1 wherein the step of classifying said plaque comprises classifying said plaque in respective classes representing plaque composed of deposits, plaque composed of small vessels, plaque composed of inflammations, plaque composed of fibrous tissue, and plaque composed of calcifications.
15. A method as claimed in claim 1 comprising obtaining said data for said first, second and third magnetic resonance images using a FLASH sequence.
16. A method as claimed in claim 1 comprising injecting Gd-DTPA into the vascular system of said subject as said contrast agent.
17. A magnetic resonance imaging apparatus comprising:
a magnetic resonance scanner adapted to receive a living subject therein, said subject having a vascular system with vessels containing plaque;
a contrast agent injector adapted to inject contrast agent, that interacts with said plaque, into the vascular system of the living subject situated in said magnetic resonance scanner, said contrast agent interacting non-uniformly with said plaque with respect to time and thus producing different intensity distributions in said plaque in a time period;
a system computer connected to said magnetic resonance scanner for operating said magnetic resonance scanner to implement a magnetic resonance imaging sequence to obtain data representing a first magnetic resonance image with a first intensity distribution of a cross-section of a vessel at the subject and said plaque therein, of said subject before injecting said contrast agent, and to re-implement said magnetic resonance imaging sequence to obtain data in said time period that represent a second magnetic resonance image of said cross-section of said vessel and said plaque therein with a second intensity distribution after a first time duration following injection of said contrast agent, and to again re-implement said magnetic resonance imaging sequence to obtain data in said time period that represent a third magnetic resonance image of said cross-section of said vessel and said plaque therein with a third intensity distribution after a second time duration following injection of said contrast agent, said second and third intensity distributions differing from each other due to said non-uniform interaction of said contrast agent with said plaque in said time period; and
a diagnostic computer supplied with said data for said first, second and third magnetic resonance images for classifying said plaque dependent on said first, second and third intensity distributions.
18. An apparatus as claimed in claim 17 wherein said diagnostic computer classifies said plaque in different classes of plaque dependent on propensity to dislodge from said vessel.
19. An apparatus as claimed in claim 17 wherein said system computer sets said first time duration to lie within an enrichment phase of said contrast agent in said plaque.
20. An apparatus as claimed in claim 17 wherein said system computer sets said time duration as approximately one minute.
21. An apparatus as claimed in claim 19 wherein said system computer sets said second time duration to lie within a flushing phase of said contrast agent in said plaque, following said enrichment phase.
22. An apparatus as claimed in claim 21 wherein said system computer sets said second time duration as approximately three minutes.
23. An apparatus as claimed in claim 17 wherein said system computer operates said magnetic resonance scanner to obtain data from a same region of said subject in each of said first, second and third magnetic resonance images and wherein said diagnostic computer determines the respective first, second and third intensity distributions in said region.
24. An apparatus as claimed in claim 23 wherein said diagnostic computer defines a same line in each of said first, second and third magnetic resonance images, and determines the respective first, second and third intensity distributions along said line.
25. An apparatus as claimed in claim 17 wherein said diagnostic computer classifies said plaque in a plurality of classes including a class representing plaque composed of fat deposits.
26. An apparatus as claimed in claim 17 wherein said diagnostic computer classifies said plaque in a plurality of classes including a class representing plaque composed of small vessels.
27. An apparatus as claimed in claim 17 wherein said diagnostic computer classifies said plaque in a plurality of classes including a class representing plaque composed of inflammations.
28. An apparatus as claimed in claim 17 wherein said diagnostic computer classifies said plaque in a plurality of classes including a class representing plaque composed of fibrous tissue.
29. An apparatus as claimed in claim 17 wherein said diagnostic computer classifies said plaque in a plurality of classes including a class representing plaque composed of calcifications.
30. An apparatus as claimed in claim 17 wherein said diagnostic computer classifies said plaque in respective classes representing plaque composed of deposits, plaque composed of small vessels, plaque composed of inflammations, plaque composed of fibrous tissue, and plaque composed of calcifications.
31. An apparatus as claimed in claim 17 wherein said system computer operates said magnetic resonance scanner to obtain said data for said first, second and third magnetic resonance images using a FLASH sequence.
32. An apparatus as claimed in claim 17 wherein said contrast agent injector injects Gd-DTPA into the vascular system of said subject as said contrast agent.
33. An apparatus as claimed in claim 17 wherein said contrast agent injector is operated by said system computer to inject said contrast agent.
US10/625,392 2003-07-23 2003-07-23 Magnetic resonance method and apparatus for classifying an atheroma Expired - Fee Related US7328056B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/625,392 US7328056B2 (en) 2003-07-23 2003-07-23 Magnetic resonance method and apparatus for classifying an atheroma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/625,392 US7328056B2 (en) 2003-07-23 2003-07-23 Magnetic resonance method and apparatus for classifying an atheroma

Publications (2)

Publication Number Publication Date
US20050033178A1 US20050033178A1 (en) 2005-02-10
US7328056B2 true US7328056B2 (en) 2008-02-05

Family

ID=34115714

Family Applications (1)

Application Number Title Priority Date Filing Date
US10/625,392 Expired - Fee Related US7328056B2 (en) 2003-07-23 2003-07-23 Magnetic resonance method and apparatus for classifying an atheroma

Country Status (1)

Country Link
US (1) US7328056B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137711A1 (en) * 2008-11-25 2010-06-03 Trustees Of Boston University Apparatus and Method of Analyzing Arterial Plaque
DE102009008623B3 (en) * 2009-02-12 2010-12-30 Siemens Aktiengesellschaft Method and arrangement for the transmission of magnetic resonance signals

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5579767A (en) * 1993-06-07 1996-12-03 Prince; Martin R. Method for imaging abdominal aorta and aortic aneurysms
US6415048B1 (en) * 1993-10-12 2002-07-02 Schneider Medical Technologies, Inc. Compositional analysis system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5579767A (en) * 1993-06-07 1996-12-03 Prince; Martin R. Method for imaging abdominal aorta and aortic aneurysms
US6415048B1 (en) * 1993-10-12 2002-07-02 Schneider Medical Technologies, Inc. Compositional analysis system

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Cai et al. Circulation. Classification of Human Carotid Atherosclerotic Lesions with In Vivo Multicontrast Magnetic Resonance Imaging. 106:1368-1373. Aug. 19, 2002.□□. *
Choudhury et al. MRI and Characterization of Atherosclerotic Plaque: Emerging Applications and Molecular Imaging. Arterioscler. Thromb. Vasc. Biol. 2002. 22:1065-1074. Apr. 25, 2002. *
Clarke et al. Identification of atherosclerotic plaque components using cluster analysis of multispectral MR images: comparison with histology. Proc. SPIE Int. Soc. Opt. Eng. 3978, 304-311. Apr. 2000. *
Flacke et al. Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques. Circulation. Sep. 11, 2001; 104(11):pp. 1280-1285. *
Mofidi et al. Angiogenesis in carotid atherosclerosis: the association with morphological features of plaque instability. British Journal of Surgery. 88:603. 2001. *

Also Published As

Publication number Publication date
US20050033178A1 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
US6952097B2 (en) Method for slice position planning of tomographic measurements, using statistical images
US7078901B2 (en) Method and magnetic resonance system for homogenizing the B1 field
CN100369579C (en) Nuclear self rotating tomographic device with image forming angiographic measuring unit
US7511489B2 (en) MRT imaging on the basis of conventional PPA reconstruction methods
US7990140B2 (en) MRI apparatus
US7719270B2 (en) Method and apparatus for accelerated spiral-coded imaging in magnetic resonance tomography
US6888350B2 (en) Medical apparatus and computer program product for magnetic resonance imaging with interactive contrast optimization
US8115484B2 (en) Method and device to generate a measurement sequence for operating a magnetic resonance system that is adapted to the time raster of the system
US7609058B2 (en) Method and apparatus for generating a magnetic resonance data file
US7570985B2 (en) Method and apparatus for magnetic resonance imaging using contrast agent
US6870367B2 (en) Magnetic resonance imaging (MRI) with continuous table motion
US20050165295A1 (en) Local magnetic resonance image quality by optimizing imaging frequency
US7480527B2 (en) Magnetic resonance imaging method and apparatus with non-selective excitation of the examination subject
US20100052677A1 (en) Magnetic resonance imaging system and magnetic resonance imaging method
US6483306B2 (en) Magnetic resonance tomography apparatus and method for generating a magnetic resonance image of a subject with different pulse sequences in K-space
US7328056B2 (en) Magnetic resonance method and apparatus for classifying an atheroma
US9739856B2 (en) Magnetic resonance imaging method and apparatus with interleaved resting state functional magnetic resonance imaging sequences and morphological magnetic resonance imaging sequences
Kneeland et al. Magnetic resonance imaging systems: optimization in clinical use.
US4970465A (en) Magnetic resonance imaging system and method
US9354290B2 (en) Method and magnetic resonance system to generate an MR image with a tracking factor
US9316712B2 (en) Magnetic resonance method and apparatus using dual echoes for data acquisition
US6369569B1 (en) Magnetic resonance tomography apparatus and operating method for displaying tissue contrasts with a short measuring time
US6759848B2 (en) Magnetic resonance method and apparatus for spatially resolved presentation of change in the functional activities of a brain
US5028871A (en) Magnetic resonance imaging system
US6683453B2 (en) Magnetic resonance apparatus for obtaining NMR navigator echoes with slight disturbance of the longitudinal magnetization

Legal Events

Date Code Title Description
AS Assignment

Owner name: SIEMENS AKTIENGESELLSCHAFT, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ASSMANN, STEFAN;SCHRECK, OLIVER;FINN, PAUL;AND OTHERS;REEL/FRAME:014325/0418;SIGNING DATES FROM 20030428 TO 20030718

AS Assignment

Owner name: SIEMENS AKTIENGESELLSCHAFT, GERMANY

Free format text: CORRECTIVE ASSIGNMENT TO RECORD ADDITIONAL RECEIVING PARTY, PREVIOUSLY RECORDED REEL 014325, FRAME 0418;ASSIGNORS:ASSMANN, STEFAN;SCHRECK, OLIVER;FINN, PAUL;AND OTHERS;REEL/FRAME:015904/0566;SIGNING DATES FROM 20030428 TO 20030718

Owner name: NORTHWESTERN UNIVERSITY, ILLINOIS

Free format text: CORRECTIVE ASSIGNMENT TO RECORD ADDITIONAL RECEIVING PARTY, PREVIOUSLY RECORDED REEL 014325, FRAME 0418;ASSIGNORS:ASSMANN, STEFAN;SCHRECK, OLIVER;FINN, PAUL;AND OTHERS;REEL/FRAME:015904/0566;SIGNING DATES FROM 20030428 TO 20030718

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362

FP Lapsed due to failure to pay maintenance fee

Effective date: 20160205